GNPX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Genprex Inc

NASDAQ | GNPX

0.22

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$5.49M

Market Cap

0.192

P/E Ratio

0.81

EPS

$3.97

52 Week High

$0.14

52 Week Low

HEALTHCARE

Sector

GNPX Chart

Recent Chart
Price Action

GNPX Technicals

Tags:

GNPX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.7K
Total Revenue $0
Cost Of Revenue $6.7K
Costof Goods And Services Sold $6.7K
Operating Income -$21M
Selling General And Administrative $11B
Research And Development $11M
Operating Expenses $21M
Investment Income Net -
Net Interest Income $64K
Interest Income $64K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7K
Income Before Tax -$21M
Income Tax Expense -$21B
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$21M
Net Income -$21B

Revenue & Profitability

Earnings Performance

GNPX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.1M
Total Current Assets $2.1M
Cash And Cash Equivalents At Carrying Value $1.6M
Cash And Short Term Investments $1.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $1.6B
Other Current Assets $476K
Other Non Current Assets -
Total Liabilities $2.5M
Total Current Liabilities $2.5M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.4M
Other Non Current Liabilities -
Total Shareholder Equity $1.6M
Treasury Stock -
Retained Earnings -$155M
Common Stock $11K
Common Stock Shares Outstanding $4M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$17M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.7K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $1.2K
Cashflow From Financing $12M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $277M
Dividend Payout Common Stock $277M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$21M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.7K
Total Revenue $0
Cost Of Revenue $6.7K
Costof Goods And Services Sold $6.7K
Operating Income -$21M
Selling General And Administrative $11B
Research And Development $11M
Operating Expenses $21M
Investment Income Net -
Net Interest Income $64K
Interest Income $64K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7K
Income Before Tax -$21M
Income Tax Expense -$21B
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$21M
Net Income -$21B

GNPX News

GNPX Profile

Genprex Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.

NXTT
+2.65%
$0.14
NVDA
-2.70%
$167.02
HOUR
+93.12%
$3.65
CGBS
-39.47%
$0.03
PRSO
+68.70%
$1.38
KVUE
-9.34%
$18.62
GNPX
+47.39%
$0.22
ISPC
+27.42%
$0.85
TSLA
+3.63%
$350.84
SNAP
+3.03%
$7.30
SOUN
+7.29%
$14.26
YAAS
-63.98%
$0.10
AAL
+1.71%
$13.08
RIVN
+3.72%
$14.21
VEEE
+46.39%
$2.84
AVGO
+9.40%
$334.89
AMD
-6.58%
$151.13
PLTR
-1.79%
$153.34
GELS
+62.50%
$1.56
SOFI
+0.86%
$25.60
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
WBD
+2.88%
$12.11
MARA
+0.52%
$15.19
NIO
-2.93%
$5.95
INTC
-0.48%
$24.49
HOOD
-1.61%
$101.25
AAPL
-0.03%
$239.69
LYT
-16.77%
$0.09
BBD
+3.58%
$3.18
ETHD
-2.46%
$3.56
IXHL
-9.48%
$0.52
DNN
+3.07%
$2.35
F
+0.51%
$11.74
TLRY
-2.95%
$1.14
BMNR
-0.82%
$41.84
BTG
+3.21%
$4.17
BAC
-1.12%
$49.77
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ABEV
+1.82%
$2.23
RIOT
+0.98%
$13.29
VHAI
0.00%
$0.00
AMZN
-1.42%
$232.33
LULU
-18.57%
$167.80
AEO
+0.10%
$18.80
ADAP
-19.60%
$0.04
SRM
+53.27%
$10.30
GRAB
+2.17%
$5.16
PFE
+1.38%
$24.88
GOOGL
+0.77%
$234.09
LDI
+26.75%
$2.89
LCID
+13.92%
$18.41
NOK
-1.08%
$4.55
RGTI
-0.13%
$15.10
ONDS
+4.95%
$5.59
QBTS
+0.52%
$15.37
PLUG
+1.38%
$1.46
KEY
-1.25%
$18.94
EQX
+9.03%
$9.77
MSFT
-2.55%
$495.00
JBLU
-0.19%
$5.08
SBET
-3.20%
$14.93
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
HBAN
-1.29%
$17.64
WLGS
-5.57%
$0.04
MU
+5.76%
$131.37
CIFR
+1.62%
$7.52
AGNC
+1.66%
$10.37
JOBY
+2.74%
$13.46
RR
-0.39%
$2.52
ETWO
0.00%
$3.30
WULF
+2.93%
$9.13
BTE
-3.31%
$2.18
GOOG
+1.07%
$235.17
VALE
+1.36%
$10.40
MRVL
-1.20%
$63.33
DUO
+32.81%
$3.44
T
+0.03%
$29.59
HPE
+1.55%
$23.52
CAN
+3.26%
$0.70
HIMS
+0.62%
$48.41
KO
-0.42%
$67.95
AFMD
-34.94%
$0.18
IREN
+0.07%
$26.15
BURU
-5.54%
$0.14
CLF
+8.27%
$11.39
ITUB
+1.57%
$7.10
PBR
-1.63%
$12.17
OPAD
+4.71%
$5.11
NUVB
+14.03%
$3.90
SMCI
-0.71%
$40.40
KDP
-2.05%
$28.65
FIG
+0.54%
$54.85
WFC
-3.50%
$78.95
AG
+0.88%
$9.15
AMCR
-0.65%
$8.29
UBER
-1.07%
$90.99
RIG
-0.96%
$3.07
NXTT
+2.65%
$0.14
NVDA
-2.70%
$167.02
HOUR
+93.12%
$3.65
CGBS
-39.47%
$0.03
PRSO
+68.70%
$1.38
KVUE
-9.34%
$18.62
GNPX
+47.39%
$0.22
ISPC
+27.42%
$0.85
TSLA
+3.63%
$350.84
SNAP
+3.03%
$7.30
SOUN
+7.29%
$14.26
YAAS
-63.98%
$0.10
AAL
+1.71%
$13.08
RIVN
+3.72%
$14.21
VEEE
+46.39%
$2.84
AVGO
+9.40%
$334.89
AMD
-6.58%
$151.13
PLTR
-1.79%
$153.34
GELS
+62.50%
$1.56
SOFI
+0.86%
$25.60
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
WBD
+2.88%
$12.11
MARA
+0.52%
$15.19
NIO
-2.93%
$5.95
INTC
-0.48%
$24.49
HOOD
-1.61%
$101.25
AAPL
-0.03%
$239.69
LYT
-16.77%
$0.09
BBD
+3.58%
$3.18
ETHD
-2.46%
$3.56
IXHL
-9.48%
$0.52
DNN
+3.07%
$2.35
F
+0.51%
$11.74
TLRY
-2.95%
$1.14
BMNR
-0.82%
$41.84
BTG
+3.21%
$4.17
BAC
-1.12%
$49.77
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ABEV
+1.82%
$2.23
RIOT
+0.98%
$13.29
VHAI
0.00%
$0.00
AMZN
-1.42%
$232.33
LULU
-18.57%
$167.80
AEO
+0.10%
$18.80
ADAP
-19.60%
$0.04
SRM
+53.27%
$10.30
GRAB
+2.17%
$5.16
PFE
+1.38%
$24.88
GOOGL
+0.77%
$234.09
LDI
+26.75%
$2.89
LCID
+13.92%
$18.41
NOK
-1.08%
$4.55
RGTI
-0.13%
$15.10
ONDS
+4.95%
$5.59
QBTS
+0.52%
$15.37
PLUG
+1.38%
$1.46
KEY
-1.25%
$18.94
EQX
+9.03%
$9.77
MSFT
-2.55%
$495.00
JBLU
-0.19%
$5.08
SBET
-3.20%
$14.93
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
HBAN
-1.29%
$17.64
WLGS
-5.57%
$0.04
MU
+5.76%
$131.37
CIFR
+1.62%
$7.52
AGNC
+1.66%
$10.37
JOBY
+2.74%
$13.46
RR
-0.39%
$2.52
ETWO
0.00%
$3.30
WULF
+2.93%
$9.13
BTE
-3.31%
$2.18
GOOG
+1.07%
$235.17
VALE
+1.36%
$10.40
MRVL
-1.20%
$63.33
DUO
+32.81%
$3.44
T
+0.03%
$29.59
HPE
+1.55%
$23.52
CAN
+3.26%
$0.70
HIMS
+0.62%
$48.41
KO
-0.42%
$67.95
AFMD
-34.94%
$0.18
IREN
+0.07%
$26.15
BURU
-5.54%
$0.14
CLF
+8.27%
$11.39
ITUB
+1.57%
$7.10
PBR
-1.63%
$12.17
OPAD
+4.71%
$5.11
NUVB
+14.03%
$3.90
SMCI
-0.71%
$40.40
KDP
-2.05%
$28.65
FIG
+0.54%
$54.85
WFC
-3.50%
$78.95
AG
+0.88%
$9.15
AMCR
-0.65%
$8.29
UBER
-1.07%
$90.99
RIG
-0.96%
$3.07
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.